Revolution Medicines, Inc. (RVMD)
176.35
-4.35
(-2.41%)
USD |
NASDAQ |
Nov 12, 16:00
176.07
-0.28
(-0.16%)
After-Hours: 06:39
Revolution Medicines Profit Margin (Quarterly) : -206.2% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -206.2% |
| June 30, 2026 | |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | -21.77K% |
| September 30, 2023 | |
| June 30, 2023 | -2.57K% |
| March 31, 2023 | -970.9% |
| December 31, 2022 | -368.6% |
| Date | Value |
|---|---|
| September 30, 2022 | -2.19K% |
| June 30, 2022 | -671.6% |
| March 31, 2022 | -760.7% |
| December 31, 2021 | -556.8% |
| September 30, 2021 | -4.81K% |
| June 30, 2021 | -509.3% |
| March 31, 2021 | -367.0% |
| December 31, 2020 | -390.9% |
| September 30, 2020 | -215.0% |
| June 30, 2020 | -271.5% |
| March 31, 2020 | -169.1% |
| December 31, 2019 | -120.7% |
| September 30, 2019 | -102.5% |
| June 30, 2019 | -82.40% |
| March 31, 2019 | -76.95% |
| December 31, 2018 | -109.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | 12.34% |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Intellia Therapeutics, Inc. | -1.78K% |
| Twist Bioscience Corp. | -29.61% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.06% |
| Return on Assets | -60.18% |
| Return on Invested Capital | -71.07% |
| Gross Profit Margin (Quarterly) | 97.26% |
| Operating Margin (Quarterly) | -188.9% |
| Return on Net Operating Assets | -663.3% |